Pharmacological studies have shown that ROCK inhibition ameliorates diabetes-induced cardiac dysfunction [131–133] and a study using heterozygous ROCK2 KO mice demonstrated that ROCK2 phosphorylates ryanodine receptors, impairing cardiac Ca2+ homeostasis [134]. The gene discussed is ROCK2; the disease is diabetes mellitus.